Leishmune® vaccine:: The newest tool for prevention and control of canine visceral leishmaniosis and its potential as a transmission-blocking vaccine

被引：47
|
作者：
Dantas-Torres, Filipe [1 ]
机构：
[1] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Imunol, BR-50670420 Recife, PE, Brazil
来源：
VETERINARY PARASITOLOGY | 2006年 / 141卷 / 1-2期
关键词：
zoonotic visceral leishmaniosis; dogs; vaccination; prevention; control;
D O I：
10.1016/j.vetpar.2006.05.001
中图分类号：
R38 [医学寄生虫学]; Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ; 100103 ;
摘要：
Canine visceral leishmaniosis is a life-threatening disease caused by Leishmania infantum. For quite some time, specialists in leishmaniosis have tried to develop more affordable and effective control measures against this disease. In this search, the first vaccine against canine visceral leishmaniosis was recently licensed in Brazil. In the light of recent research, the Leishmune (R) vaccine might be seen as the newest tool for prevention and control of canine visceral leishmaniosis. Moreover, the potential of the Leishmune (R) as a transmission-blocking vaccine has recently been demonstrated, indicating its usefulness in the control of 66 zoonotic visceral leishmaniosis. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码：1 / 8
页数：8
相关论文
共 11 条
  • [1] The FML-vaccine (Leishmune®) against canine visceral leishmaniasis:: A transmission blocking vaccine
    Saraiva, EM
    Barbosa, AD
    Santos, FN
    Borja-Cabrera, GP
    Nico, D
    Souza, LOP
    Mendes-Aguiara, CD
    de Souzaa, EP
    Fampa, P
    Parra, LE
    Menz, I
    Dias, JG
    de Oliveira, SM
    Palatnik-de-Sousa, CB
    VACCINE, 2006, 24 (13) : 2423 - 2431
  • [2] MOSQUITO MIDGUT FREP1 IS A POTENTIAL UNIVERSAL MALARIA TRANSMISSION-BLOCKING VACCINE
    Franca, Caio Martinelle
    Niu, Guodong
    Zhang, Genwei
    Roobsoong, Wanlapa
    Wang, Nguitragool
    Wang, Xioahong
    Kim, Jang
    Prachumsri, Jetsumon
    Bulter, Noah
    Li, Jun
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 191 - 191
  • [3] An analytical review of vector- and pathogen-based transmission-blocking vaccine for malaria control
    Jakhar, Renu
    Sehrawat, Neelam
    Gakhar, S.
    JOURNAL OF VECTOR BORNE DISEASES, 2022, 59 (01) : 1 - 11
  • [4] Leishmune® vaccine blocks the transmission of canine visceral leishmaniasis -: Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
    Nogueira, FS
    Moreira, MAB
    Borja-Cabrera, GP
    Santos, FN
    Menz, I
    Parra, LE
    Xu, Z
    Chu, HJ
    Palatnik-de-Sousa, CB
    Luvizotto, MCR
    VACCINE, 2005, 23 (40) : 4805 - 4810
  • [5] An Optimal Control Model to Understand the Potential Impact of the New Vaccine and Transmission-Blocking Drugs for Malaria: A Case Study in Papua and West Papua, Indonesia
    Handari, Bevina D.
    Ramadhani, Rossi A.
    Chukwu, Chidozie W.
    Khoshnaw, Sarbaz H. A.
    Aldila, Dipo
    VACCINES, 2022, 10 (08)
  • [6] Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine
    Miyata, Takeshi
    Harakuni, Tetsuya
    Sugawa, Hideki
    Sattabongkot, Jetsumon
    Kato, Aki
    Tachibana, Mayumi
    Torii, Motomi
    Tsuboi, Takafumi
    Arakawa, Takeshi
    VACCINE, 2011, 29 (15) : 2720 - 2726
  • [7] Plasmodium vivax HAP2 genetic diversity and population structure from worldwide clinical samples. A potential Transmission-Blocking malaria vaccine candidate
    Saif, Ahmed
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2024, 36 (07)
  • [8] The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
    Shwu-Maan Lee
    Yimin Wu
    John M. Hickey
    Kazutoyo Miura
    Neal Whitaker
    Sangeeta B. Joshi
    David B. Volkin
    C. Richter King
    Jordan Plieskatt
    Malaria Journal, 18
  • [9] The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate
    Lee, Shwu-Maan
    Wu, Yimin
    Hickey, John M.
    Miura, Kazutoyo
    Whitaker, Neal
    Joshi, Sangeeta B.
    Volkin, David B.
    Richter King, C.
    Plieskatt, Jordan
    MALARIA JOURNAL, 2019, 18 (01)
  • [10] Adenovirus-vectored Plasmodium vivax ookinete surface protein, Pvs25, as a potential transmission-blocking vaccine (vol 29, pg 2720, 2011)
    Miyata, Takeshi
    Harakuni, Tetsuya
    Sugawa, Hideki
    Sattabongkot, Jetsumon
    Kato, Aki
    Tachibana, Mayumi
    Torii, Motomi
    Tsuboi, Takafumi
    Arakawa, Takeshi
    VACCINE, 2011, 29 (23) : 4077 - 4077
12